Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3U19AI118626-06S1
Grant search
Key facts
Disease
DengueStart & end year
20202022Known Financial Commitments (USD)
$292,800Funder
National Institutes of Health (NIH)Principal Investigator
Alessandro SetteResearch Location
United States of AmericaLead Research Institution
LA JOLLA INSTITUTE FOR IMMUNOLOGYResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
Data Management and Data Sharing
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Our group has developed a set of data standards over the years to capture different aspects of immune profiling studies that enable the description of, for example, the immune exposure being studied (e.g. type and course of infection or vaccination) or the molecular markers measured in a cytometry assay and how they relate detected cells to specific cell types. These standards were primarily developed for the Human Immunology Project Consortium (HIPC), and were tailored to be interoperable with the ImmPort submission system, in which they have been adopted and are now used for all data submissions into ImmPort. For HIPC, these standards have enabled cross-center data analysis projects and method development. As part of this work, automated validation routines have been created that test ImmPort data submissions for their adherence to these data standards, which has enabled us to identify and correct issues in data submissions..